Loading chat...
MA S1711
Bill
AI Summary
-
All state and county correctional facilities must offer FDA-approved medication for addiction treatment (MAT) to detained, committed, or incarcerated persons upon recommendation of a qualified addiction specialist, with assessments required within 24 hours of admission
-
Incarcerated individuals already receiving MAT prior to custody must continue receiving the same medication and dosage within 24 hours unless clinically contraindicated; positive drug screenings cannot be used to deny treatment or impose disciplinary infractions
-
Re-entry treatment plans must be established at least 120 days before discharge (or 30 days minimum for shorter sentences), including referrals to community providers, at least 2 doses of an opioid antagonist, and assistance with MassHealth enrollment
-
Facilities are prohibited from using incentives, rewards, or punishments to influence an individual's decision to accept or decline addiction treatment
-
Correctional facilities must submit semi-annual reports to the Department of Public Health and legislative committees tracking MAT utilization, overdoses, treatment continuity, and post-release outcomes
Legislative Description
Regarding consistent care for addiction rooted in evidence
Last Action
Accompanied a study order, see S2972
2/26/2026